N0937 (Alliance): Final clinical results and correlative data from the phase II trial of cisplatin (C) and the novel agent brostallicin (B) in patients with metastatic triple-negative breast cancer (mTNBC)
- Citation:
- J Clin Oncol vol 31 (15 suppl) abstr 1059
- Meeting Instance:
- ASCO 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- A. Moreno-Aspitia H. Liu D. Hillman K. M. Rowland Jr X. Geiger P. J. Stella P. Kourlas H. M. Gross N. Karlin M. J. Bury G. S. Soori A. Nassar E. A. Perez
- Networks:
- Study
- NCCTG-N0937
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: